NCT06249399

Brief Summary

The goal of this clinical trial is to investigate the effect of aerobic exercise (AE) on bladder functions and urinary system symptoms in women diagnosed with Diabetes Mellitus (DM) and suffered from Lower Urinary Tract Symptoms (LUTS). In the study, 44 individuals (35-55 age) were divided into two groups: Aerobic Exercise (AE) (n=22) and Control Group (n=22) by simple random method. The main questions it aims to answer are:

  • Is aerobic exercise effective on bladder functions in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
  • Is aerobic exercise effective on urinary tract symptoms in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
  • Is aerobic exercise effective on quality of life in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms? Intervention/treatment
  • Control group individuals will be given a behavioral treatment program.
  • Submaximal aerobic exercise training will be given to the AE group in addition to the behavioral treatment program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

10 months

First QC Date

January 12, 2024

Last Update Submit

March 1, 2024

Conditions

Keywords

Lower urinary tract symptomsDiabetes Mellitus, Type 2bladderaerobic exercisequality of life

Outcome Measures

Primary Outcomes (2)

  • Bladder Compliance

    Bladder compliance will be evaluated by urodynamics. With urodynamic evaluations, pathologies of the lower urinary system can be diagnosed and classified. Urodynamic examinations are performed in a suitable laboratory environment. First of all, a suitable sterile catheter is placed in the bladder and isotonic fluid is filled into it at a certain speed. In this way, the behavior of the bladder and its muscles during urine filling, pressure measurements and behavior during urination are examined. Bladder functions are evaluated with urodynamic evaluations. With the urodynamic evaluation will be performed by the clinician in the urology outpatient clinic compliance (ml/cmH2O) will be recorded.

    10 minutes (Change from Baseline at 12 weeks)

  • Bladder Sensation

    Bladder sensation will be evaluated by urodynamics. With urodynamic evaluations, pathologies of the lower urinary system can be diagnosed and classified. Urodynamic examinations are performed in a suitable laboratory environment. First of all, a suitable sterile catheter is placed in the bladder and isotonic fluid is filled into it at a certain speed. In this way, the behavior of the bladder and its muscles during urine filling, pressure measurements and behavior during urination are examined. Bladder functions are evaluated with urodynamic evaluations. With the urodynamic evaluation will be performed by the clinician in the urology outpatient clinic sensation (ml) will be recorded.

    10 minutes (Change from Baseline at 12 weeks)

Secondary Outcomes (11)

  • Voiding Volume

    10 minutes (Change from Baseline at 12 weeks)

  • Voiding Time

    10 minutes (Change from Baseline at 12 weeks)

  • Maximum Bladder Capacity

    10 minutes (Change from Baseline at 12 weeks)

  • Urine Maximum Flow Rate

    10 minutes (Change from Baseline at 12 weeks)

  • Bladder Residual Volume

    10 minutes (Change from Baseline at 12 weeks)

  • +6 more secondary outcomes

Study Arms (2)

Aerobic Exercise Group

EXPERIMENTAL

A behavioral treatment program will be applied to the patients. In addition, patients will be given submaximal aerobic exercise.

Other: Aerobic ExerciseBehavioral: Behavioral Treatment Program

Control group

ACTIVE COMPARATOR

A behavioral treatment program will be applied to the patients.

Behavioral: Behavioral Treatment Program

Interventions

Aerobic Exercise training will be provided three days a week, 45 minutes a day, for 12 weeks. Patients will be subjected to submaximal aerobic exercise with rhythmic movements without equipment via video conference accompanied by a physiotherapist.

Aerobic Exercise Group

Behavioral Treatment Program will be completed with an initial training period of 40 minutes, and subsequent control interviews of 20 minutes at four-week intervals.

Aerobic Exercise GroupControl group

Eligibility Criteria

Age35 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women between the ages of 35-55,
  • Individuals who volunteer to participate in the study,
  • Those diagnosed with Type II diabetes for 5 years or more and those diagnosed with LUTS

You may not qualify if:

  • Stage 2 and more advanced pelvic organ prolapse,
  • Urinary tract infection,
  • Has had previous surgery for urinary incontinence and pelvic organ prolapse,
  • Diagnosis of Cerebro Vascular Event (CVE) and dementia,
  • Using A-blockers, antimuscarinics, antidepressants, diuretics and antihistamines,
  • Individuals in menopause.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasan Kalyoncu University

Gaziantep, 27000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lower Urinary Tract SymptomsDiabetes Mellitus, Type 2

Interventions

Exercise

Condition Hierarchy (Ancestors)

Urological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Bengisu TÜFEKÇİ

    Hasan Kalyoncu University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two groups: aerobic exercise group and control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 12, 2024

First Posted

February 8, 2024

Study Start

May 3, 2023

Primary Completion

March 1, 2024

Study Completion

March 1, 2024

Last Updated

March 5, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations